COVID: Italian Takis vaccine trials start

(ANSA) – ROME, MAR 1 – Trials started Monday of a new Italian
COVID vaccine conceived by the Takis firm at Castel Romano near
    The vaccine is being developed in collaboration with the
Rottapharm Biotech company of Monza.
    The first over-80 volunteer was vaccinated Monday at Monza’s San
Gerardo Hospital.
    This is one of three Italian centres where the trials are taking
place, in collaboration with the Università di Milano-Bicocca.
    Also involved are Naples Pascale national tumour institute and
Rome’s Spallanzani infectious disease hospital.
    Another Italian vaccine, made by ReiThera near Rome, is expected
to be available from this autumn. (ANSA).


Italy must take more steps on reforms – Gentiloni

COVID: Epidemic showing ‘exponential growth’ – CNR


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.